Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
For patients with contraindications to GLP-1 receptor agonists, numerous effective alternatives exist for managing type 2 diabetes and obesity
Tirzepatides Proven Impact Tirzepatide has demonstrated robust clinical benefits in multiple large-scale trials
This agonist triggers the natural hormone our bodies produce that helps us feel full after eating, leading to less frequent hunger cues, a slower digestive rate, and, potentially, fewer blood sugar changes
4.4 Japan: PMDA The PMDA has historically required comparability studies against locally sourced reference products, which adds cost and time for biosimilar developers who have already compared against US- or EU-sourced reference products
IM up to 3/week provides less frequent, moderate dosing
